Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Voriconazole for Invasive Fungal Infections
NCT00001940Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole in invasive fungal infection (IFI), sponsored by National Cancer Institute. Started Dec 1999; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00001940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001940.